Pharmaceuticals APAC

APAC PTSD Treatment Market Analysis, 2024–2034

APAC PTSD Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Population, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $381.7 Mn Estimated value
Estimate 2025 $408.8 Mn 24.3% of the global market
Projected 2034 $757.9 Mn 85.4% Adds $349.1 Mn over 9 forecast years
CAGR 2025–2034 7.1% Faster than 24% of 180 Pharmaceuticals markets here
Key players 5
  • APAC is 24.26% of the global market.
  • Among regions, the largest is North America at $783.1 Mn.
  • Fastest growing: Africa at 7.4% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$349.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
PTSD Treatment Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $381.7 Mn — —
2025 (base) $408.8 Mn +$27.1 Mn —
2026 (forecast) $437.8 Mn +$29.0 Mn +7.1%
2027 (forecast) $468.9 Mn +$31.1 Mn +14.7%
2028 (forecast) $502.2 Mn +$33.3 Mn +22.8%
2029 (forecast) $537.9 Mn +$35.7 Mn +31.6%
2030 (forecast) $576.1 Mn +$38.2 Mn +40.9%
2031 (forecast) $617.0 Mn +$40.9 Mn +50.9%
2032 (forecast) $660.8 Mn +$43.8 Mn +61.6%
2033 (forecast) $707.7 Mn +$46.9 Mn +73.1%
2034 (forecast) $757.9 Mn +$50.2 Mn +85.4%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.69 Bn
  2. North America $783.1 Mn
  3. US $760.0 Mn
  4. APAC (this report) $408.8 Mn
  5. Europe $271.4 Mn
  6. China $132.5 Mn
  7. Japan $121.1 Mn
  8. Canada $118.1 Mn
  9. Latin America $77.9 Mn
  10. Germany $67.3 Mn
  11. Middle East $64.2 Mn
  12. UK $42.7 Mn
  13. France $43.2 Mn
  14. Brazil $43.9 Mn
  15. Italy $34.7 Mn
  16. Ecuador $33.1 Mn
  17. India $31.7 Mn
  18. Spain $29.0 Mn
  19. Saudi Arabia $29.5 Mn
  20. Mexico $27.2 Mn
  21. Africa $25.1 Mn
  22. Australia $22.3 Mn
  23. Russia $19.0 Mn
  24. New Zealand $16.5 Mn
  25. South Africa $11.7 Mn
  26. UAE $9.5 Mn
  27. Egypt $4.4 Mn
  28. Philippines $4.0 Mn
  29. Malaysia $3.1 Mn
  30. Hong Kong $2.5 Mn
  31. Singapore $1.9 Mn
  32. Thailand $1.9 Mn
  33. Kenya $1.2 Mn

The APAC PTSD Treatment Market Analysis Executive Summary

PTSD treatment helps people recover from trauma using therapies, medicines and new approaches such as MDMA-assisted therapy.

Key segments of the PTSD Treatment market include treatment (Psychotherapy, SSRIs and SNRIs and Psychedelic-Assisted Therapy) and population (Veterans and Military and Civilians).

APAC PTSD Treatment Market Dynamics

Market Growth Drivers

More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the PTSD Treatment market. Governments and employers are investing more in mental health care.

Opportunity

Digital tools, new drug classes and care built into primary care and workplaces give the PTSD Treatment market strong room to grow worldwide.

Market Restraints

Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the PTSD Treatment market.

Competitive Landscape for PTSD Treatment Market in APAC

The PTSD Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for PTSD Treatment Market in APAC

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for PTSD Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in PTSD Treatment right now, from free public sources.

Clinical trials

27 active trials in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand, Bangladesh, Afghanistan, Indonesia, Myanmar, Nepal and Pakistan

Recruiting, about to start, or running now. Counted across the 16 countries we report on in APAC.

Top trial sponsors (worldwide)

  1. Transcend Therapeutics 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 660 papers since 2021 (worldwide)

  1. Pharmacotherapeutic strategies for the treatment of the most frequent psychiatric comorbidities in PTSD. Expert opinion on pharmacotherapy, 2026
  2. Engagement and outcomes of veterans endorsing suicidal ideation in a couple-based treatment for posttraumatic stress disorder. Journal of traumatic stress, 2026
  3. The effects of gender on response to prolonged exposure therapy for posttraumatic stress disorder among adults receiving medications for opioid use disorder. Psychological trauma : theory, research, practice and policy, 2026
  4. Adapted Massed Exposure Therapy Enhanced with MDMA for PTSD (aMETEMP): A randomized, double-masked protocol adapted for Veterans Affairs healthcare system. Contemporary clinical trials communications, 2026
  5. Cannabidiol prevents fear extinction deficits caused by single prolonged stress in rats: possible involvement of serotoninergic, cannabinoid, and nitric mechanisms. Neuropharmacology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

PTSD Treatment in context

Questions, answered with public data

How many clinical trials on PTSD Treatment are running in APAC?
27 studies are recruiting, active or about to start in APAC, counted across the 16 countries we report on there.[1]
How much research is published on PTSD Treatment?
PubMed lists 660 papers added since January 2021 that match this market, worldwide.[2]

[1] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in APAC. Retrieved 12 Nov 2026.

[2] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about PTSD Treatment in APAC? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Adaptogens: Ancient Herbs, Modern Market170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and… Stress and Mood Supplements: Ashwagandha and BeyondDepression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress… Antidepressants: Demand, Access and New ApproachesAbout 322 million people live with depression. Treatment works, but most people still do not get it.
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in APAC

See all
Same topic, other categories

Related on mental health

See the topic